SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-035671
Filing Date
2021-03-12
Accepted
2021-03-12 17:15:53
Documents
18
Period of Report
2021-03-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm219261d2_8k.htm   iXBRL 8-K 29368
2 EXHIBIT 16.1 tm219261d2_ex16-1.htm EX-16.1 5269
6 GRAPHIC logo.jpg GRAPHIC 4725
7 GRAPHIC marcum_sig.jpg GRAPHIC 2664
8 GRAPHIC footer_logo.jpg GRAPHIC 787
9 GRAPHIC footer_logo1.jpg GRAPHIC 1153
10 GRAPHIC footer_logo3.jpg GRAPHIC 798
  Complete submission text file 0001104659-21-035671.txt   224661

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iova-20210312.xsd EX-101.SCH 3175
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20210312_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20210312_pre.xml EX-101.PRE 22703
11 EXTRACTED XBRL INSTANCE DOCUMENT tm219261d2_8k_htm.xml XML 3620
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 21738511
SIC: 2836 Biological Products, (No Diagnostic Substances)